Тёмный

Safety and Management of Side Effects of Pirfenidone and Nintedanib | Wendi Mason, MSN 

Pulmonary Fibrosis Foundation
Подписаться 15 тыс.
Просмотров 9 тыс.
50% 1

Wendi Mason, MD discusses the safety and management of drug treatments for idiopathic pulmonary fibrosis and pulmonary fibrosis.
Learn more about treatment options for pulmonary fibrosis at www.pulmonaryfibrosis.org/life....
This activity is jointly provided by Postgraduate Institute for Medicine and the Pulmonary Fibrosis Foundation, in collaboration with Global Academy for Medical Education.
Please note that any information contained in this presentation is for informational and/or educational purposes only. This is not an endorsement of any specific service or medication. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider with any questions you may have regarding your specific medical condition. If you desire or need advice or referral information, please consult your health care provider or contact the PFF Patient Communication Center (PCC). (Toll Free) 844-Talk-PFF or pcc@pulmonaryfibrosis.org.
Opening Music: www.bensound.com

Опубликовано:

 

9 июл 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
Overview of Pirfenidone and Nintedanib | Joyce Lee, MD
23:20
Living with IPF - what is it really like?
9:53
Просмотров 43 тыс.
I have pulmonary fibrosis. Now what?
1:00:22
Просмотров 13 тыс.
Cough 101: An Overview of Cough in Pulmonary Fibrosis
59:33
Interstitial Lung Disease (ILD) in a Nutshell
16:50
Просмотров 197 тыс.
Using supplemental oxygen
1:09:25
Просмотров 759
The Effect of Nintedanib in IPF Subgroups
9:02
Просмотров 4,3 тыс.